Dr Sathish Harinarayanan

I am a distinguished Consultant Clinical Oncologist based in the South Coast of England. I provide expert services for patients with bowel cancers, head and neck cancers, non-melanomatous skin cancers arising in the head and neck area, and complex thyroid cancers requiring radiotherapy.

My areas of expertise also include the MRL-SABR treatment for oligometastatic cancer, a complex and modern radiotherapy technique which delivers high-dose radiotherapy more precisely to cancer with limited spread to other parts of the body. Which is otherwise not possible with conventional CT guided radiotherapy machines. I am also accredited to provide proton radiotherapy treatments.

I have a wealth of oncology experience spanning more than a decade; and am dedicated to providing the highest standard of care in clinical oncology. After graduating with a medical degree and doing various medical rotations across renowned London and West Midlands hospitals, I undertook higher specialist oncology training around Wessex hospitals and London hospitals. Before taking up my consultant post at University Hospital of Southampton NHS Trust.

With a demonstrated commitment to excellence, I undertook and completed a prestigious proton therapy clinical education programme at the University of Pennsylvania. As well as an MRL-SABR accreditation from GCUK and PGC, from the Institute of Cancer Research, London.

Beyond my clinical practice, I hold membership with the British Association of Head & Neck Oncology, served as co-chair of the Wessex Head and Neck Cancer alliance group, and am a member of the panel for the Wessex clinical oncology trainees. I am also the elected governor for medical and dental staffing for Southampton attending the trust board meetings.

I actively participate in research, being the principal investigator for the country’s leading trials like PATHOS and APHRODITE for organ preserving strategies with radiotherapy for rectal cancer patients who wish to avoid permanent stoma bags. I have also acted at a co-investigator capacity for other leading UK clinical trials in Wessex like CHECKMATE 642, LiTEFORM, KEYNOTE 412, INNOVATE and ToRPEDO and recruited several patients so far.